Announcements Trials
Browse Landscape

Status

Completed 22Recruiting 11Unknown 7Not yet recruiting 4Enrolling by invitation 4Terminated 3Active not recruiting 3Withdrawn 1Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 8Observational 3

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 138Neoplasms 134Lung Neoplasms 68Prostatic Neoplasms 67Carcinoma, Non-Small-Cell Lung 58Colorectal Neoplasms 45Multiple Myeloma 37Pancreatic Neoplasms 33Melanoma 32Head and Neck Neoplasms 30Brain Neoplasms 30Neoplasm Metastasis 28Ovarian Neoplasms 27Liver Neoplasms 27Carcinoma, Hepatocellular 27Leukemia, Myeloid, Acute 25Colonic Neoplasms 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma 20Leukemia, Lymphocytic, Chronic, B-Cell 20Esophageal Neoplasms 20Carcinoma, Renal Cell 20Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 18Stomach Neoplasms 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Lymphoma, Follicular 17Lymphoma, Large B-Cell, Diffuse 16

Interventions

Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Observational × Hypertension × Clear all
NCT03709771 2024-01-12

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

Vanderbilt University Medical Center

Terminated
2 enrolled 6 charts
DermatologicGenitourinary

Carcinoma, Renal Cell, Hypertension, Melanoma, Neoplasms

NCT00674011 2014-05-06

Hypertension in Breast Cancer Patients Receiving Bevacizumab

Dana-Farber Cancer Institute

Terminated
10 enrolled
Breast

Breast Neoplasms, Hypertension

NCT00698659 2013-12-11

Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

National University Hospital, Singapore

Terminated

Hypertension, Proteinuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡